An aberrant DNA methylation signature for predicting hepatocellular carcinoma

BACKGROUND: By the time they are clinically diagnosed, patients with hepatocellular carcinoma (HCC) are often at the advanced stage. DNA methylation has become a useful predictor of prognosis for cancer patients. Research on DNA methylation as a biomarker for assessing the risk of occurrence in HCC...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Renhua, Li, Yafei, Yu, Hao, Liu, Lin, Zhu, Changhao, Zuo, Shi, Chen, Zili
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812168/
https://www.ncbi.nlm.nih.gov/pubmed/33490179
http://dx.doi.org/10.21037/atm-20-7804

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812168/
https://www.ncbi.nlm.nih.gov/pubmed/33490179
http://dx.doi.org/10.21037/atm-20-7804

Ejemplares similares